Literature DB >> 22328229

Effect of implantation on engineered skeletal muscle constructs.

Michael L Williams1, Tatiana Y Kostrominova, Ellen M Arruda, Lisa M Larkin.   

Abstract

The development of engineered skeletal muscle would provide a viable tissue for replacement and repair of muscle damaged by disease or injury. Our current tissue-engineering methods result in three-dimensional (3D) muscle constructs that generate tension but do not advance phenotypically beyond neonatal characteristics. To develop to an adult phenotype, innervation and vascularization of the construct must occur. In this study, 3D muscle constructs were implanted into the hindlimb of a rat, along the sciatic nerve, with the sural nerve isolated, transected and sutured to the construct to encourage innervation. Aortic ring anchors were sutured to the tendons of the biceps femoris muscle so that the construct would move dynamically with the endogenous muscle. After 1 week in vivo, the constructs were explanted, evaluated for force production and stained for muscle, nerve and collagen markers. Implanted muscle constructs showed a developing capillary system, an epimysium-like outer layer of connective tissue and an increase in myofibre content. The beginning of α-bungarotoxin clustering suggests that neuromuscular junctions (NMJs) could form on the implanted muscle, given more time in vivo. Additionally, the constructs increased maximum isometric force from 192 ± 41 μN to 549 ± 103 μN (245% increase) compared to in vitro controls, which increased from 276 ± 23 μN to 329 ± 27μN (25% increase). These findings suggest that engineered muscle tissue survives 1 week of implantation and begins to develop the necessary interfaces needed to advance the phenotype toward adult muscle. However, in terms of force production, the muscle constructs need longer implantation times to fully develop an adult phenotype.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22328229      PMCID: PMC3355234          DOI: 10.1002/term.537

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  20 in total

1.  Controlling the cellular organization of tissue-engineered cardiac constructs.

Authors:  Maya Gonen-Wadmany; Lior Gepstein; Dror Seliktar
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

2.  Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studies.

Authors:  Tatiana Y Kostrominova
Journal:  Microsc Res Tech       Date:  2011-01       Impact factor: 2.769

3.  Functional evaluation of nerve-skeletal muscle constructs engineered in vitro.

Authors:  Lisa M Larkin; Jack H Van der Meulen; Robert G Dennis; Jeffrey B Kennedy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

4.  A novel bioreactor for stimulating skeletal muscle in vitro.

Authors:  Kenneth Donnelly; Alastair Khodabukus; Andrew Philp; Louise Deldicque; Robert G Dennis; Keith Baar
Journal:  Tissue Eng Part C Methods       Date:  2010-08       Impact factor: 3.056

5.  Tissue engineering of injectable muscle: three-dimensional myoblast-fibrin injection in the syngeneic rat animal model.

Authors:  Justus P Beier; Jens Stern-Straeter; Vanni T Foerster; Ulrich Kneser; G Bjoern Stark; Alexander D Bach
Journal:  Plast Reconstr Surg       Date:  2006-10       Impact factor: 4.730

6.  Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines.

Authors:  R G Dennis; P E Kosnik; M E Gilbert; J A Faulkner
Journal:  Am J Physiol Cell Physiol       Date:  2001-02       Impact factor: 4.249

7.  Vascularized three-dimensional skeletal muscle tissue-engineering.

Authors:  A K Saxena; G H Willital; J P Vacanti
Journal:  Biomed Mater Eng       Date:  2001       Impact factor: 1.300

8.  Mechanical stimulation improves tissue-engineered human skeletal muscle.

Authors:  Courtney A Powell; Beth L Smiley; John Mills; Herman H Vandenburgh
Journal:  Am J Physiol Cell Physiol       Date:  2002-11       Impact factor: 4.249

9.  The effect of implantation on scaffoldless three-dimensional engineered bone constructs.

Authors:  Michael J Smietana; Fatima N Syed-Picard; Jinjin Ma; Tatiana Kostrominova; Ellen M Arruda; Lisa M Larkin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416

10.  Cyclic mechanical stimulation favors myosin heavy chain accumulation in engineered skeletal muscle constructs.

Authors:  Gabriele Candiani; Stefania A Riboldi; Nasser Sadr; Stefano Lorenzoni; Peter Neuenschwander; Franco M Montevecchi; Sara Mantero
Journal:  J Appl Biomater Biomech       Date:  2010 May-Aug
View more
  30 in total

1.  TGF-β1 enhances contractility in engineered skeletal muscle.

Authors:  Michael R Weist; Michael S Wellington; Jacob E Bermudez; Tatiana Y Kostrominova; Christopher L Mendias; Ellen M Arruda; Lisa M Larkin
Journal:  J Tissue Eng Regen Med       Date:  2012-02-27       Impact factor: 3.963

2.  Discovery of vascular Rho kinase (ROCK) inhibitory peptides.

Authors:  Reza Abbasgholizadeh; Hua Zhang; John W Craft; Robert M Bryan; Steven J Bark; James M Briggs; Robert O Fox; Anton Agarkov; Warren E Zimmer; Scott R Gilbertson; Robert J Schwartz
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-27

Review 3.  Innervation: the missing link for biofabricated tissues and organs.

Authors:  Suradip Das; Wisberty J Gordián-Vélez; Harry C Ledebur; Foteini Mourkioti; Panteleimon Rompolas; H Isaac Chen; Mijail D Serruya; D Kacy Cullen
Journal:  NPJ Regen Med       Date:  2020-06-05

4.  A Comparison of Ovine Facial and Limb Muscle as a Primary Cell Source for Engineered Skeletal Muscle.

Authors:  Brittany L Rodriguez; Matthew H Nguyen; Rachel E Armstrong; Emmanuel E Vega-Soto; Phillip M Polkowski; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2019-10-07       Impact factor: 3.845

5.  Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo.

Authors:  Mark Juhas; George C Engelmayr; Andrew N Fontanella; Gregory M Palmer; Nenad Bursac
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

6.  Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat.

Authors:  Keith W VanDusen; Brian C Syverud; Michael L Williams; Jonah D Lee; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2014-06-23       Impact factor: 3.845

7.  Repairing Volumetric Muscle Loss in the Ovine Peroneus Tertius Following a 3-Month Recovery.

Authors:  Stoyna S Novakova; Brittany L Rodriguez; Emmanuel E Vega-Soto; Genevieve P Nutter; Rachel E Armstrong; Peter C D Macpherson; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2020-02-28       Impact factor: 3.845

Review 8.  Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue.

Authors:  Jacob P Mertens; Kristoffer B Sugg; Jonah D Lee; Lisa M Larkin
Journal:  Regen Med       Date:  2014-01       Impact factor: 3.806

9.  Label-Free, High-Throughput Purification of Satellite Cells Using Microfluidic Inertial Separation.

Authors:  Brian C Syverud; Eric Lin; Sunitha Nagrath; Lisa M Larkin
Journal:  Tissue Eng Part C Methods       Date:  2017-11-06       Impact factor: 3.056

Review 10.  Growth Factors for Skeletal Muscle Tissue Engineering.

Authors:  Brian C Syverud; Keith W VanDusen; Lisa M Larkin
Journal:  Cells Tissues Organs       Date:  2016-11-09       Impact factor: 2.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.